Möller J C, Nachtrodt G, Tegtmeyer F K, Richter A, Gortner L
Department of Pediatrics, University of Lübeck, FRG.
Dev Pharmacol Ther. 1992;19(4):178-82. doi: 10.1159/000457482.
For the prophylaxis of septicemia with coagulase-negative staphylococci in a high-risk very-low-birth-weight population, we administered 5 mg/kg of vancomycin every 12 h. Distribution volume and half-life of vancomycin were determined. Serum peak and trough levels were obtained on day 3 of treatment. With this low-dose regimen, serum concentrations in the therapeutic range were achieved in 35 of the 45 patients. Distribution volume and half-life were 0.692 liters/kg and 7.4 h, respectively. The distribution volume was not related to the gestational age; the half-life in the group of patients with a gestational age < 30 weeks was considerably higher. The 10 small-for-gestational-age children had a significantly smaller distribution volume. The vancomycin trough levels correlated with the serum creatinine concentrations and, therefore, with the gestational age. Our study indicates that this low vancomycin dose is sufficient in very-low-birth-weight infants to achieve therapeutic serum levels, being suitable for both prophylaxis and sepsis therapy.
为了对高危极低出生体重人群中凝固酶阴性葡萄球菌引起的败血症进行预防,我们每12小时给予5毫克/千克的万古霉素。测定了万古霉素的分布容积和半衰期。在治疗第3天获得血清峰浓度和谷浓度。采用这种低剂量方案,45例患者中有35例达到了治疗范围内的血清浓度。分布容积和半衰期分别为0.692升/千克和7.4小时。分布容积与胎龄无关;胎龄<30周的患者组半衰期明显更高。10例小于胎龄儿的分布容积明显更小。万古霉素谷浓度与血清肌酐浓度相关,因此也与胎龄相关。我们的研究表明,这种低剂量的万古霉素对极低出生体重婴儿足以达到治疗性血清水平,适用于预防和败血症治疗。